aeras-404

Vaccineexperimental

Clinical trial activity

6 trials · 9 clinical orgs · 0 marketing orgs

Phase 1
5
Phase 2
2
Phase 3
0
Phase 4
0

Earliest trial started Nov 1, 2007 (NCT02066428)

Timeline

2000s

  1. Jan 1, 2007

    Earliest Phase 1 Sponsor(trial)

2010s

  1. Jan 1, 2014

    Earliest Phase 2 Sponsor(trial)

Indications

Mechanism of action

Chemistry & pharmacology

Oral

No

Parenteral

No

Topical

No

Also known as

  • aeras-404

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT02075203Phase 2Feb 1, 2014Aeras, Sanofi-Aventis, The South African Tuberculosis Vaccine Initiative
NCT01861730Phase 1/Phase 2 (Phase 2)Jul 1, 2013Aeras, National Institute of Allergy and Infectious Diseases (NIAID), National Institute of Child Health and Human Development (NICHD), Sanofi-Aventis, Statens Serum Institut
NCT02420444Phase 1Jan 1, 2011Aeras, Sanofi-Aventis, University of Lausanne
NCT02109874Phase 1Dec 1, 2008Aeras, Statens Serum Institut
NCT02074956Phase 1May 1, 2008Aeras, Statens Serum Institut, University of Tampere
NCT02066428Phase 1Nov 1, 2007Aeras, Karolinska Institute, Statens Serum Institut
Showing 6 of 6 trials
Page 1 / 1

Organizations

Research & Development (9)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
AerasAcademic/Hospital6622007
Statens Serum InstitutAcademic/Hospital4022007
Sanofi-AventisFor profit3022011
Karolinska InstituteAcademic/Hospital1012007
National Institute of Allergy and Infectious Diseases (NIAID)Government1012013
National Institute of Child Health and Human Development (NICHD)Government1012013
The South African Tuberculosis Vaccine InitiativeAcademic/Hospital1012014
University of LausanneAcademic/Hospital1012011
University of TampereAcademic/Hospital1012008
9 organizations
Page 1 / 1